Cardiac Rehabilitation During Quarantine in COVID-19 Pandemic: Challenges for Center-Based Programs

Florent Besnier1, Mathieu Gayda1, Anil Nigam1

  • 1Preventive Medicine and Physical Activity Centre and Research Center, Montreal Heart Institute, Université de Montréal, Montreal, QC; Department of Medicine, Université de Montréal, Montreal, QC.

Insights

The COVID-19 pandemic disrupted cardiac rehabilitation (CR) services. Developing remote, home-based CR programs using telemedicine is crucial for public health and cardiac patient care.

Area of Science:

  • Cardiology
  • Public Health
  • Telemedicine

Background:

  • Cardiac rehabilitation (CR) is a vital, evidence-based intervention for cardiac patients.
  • The COVID-19 pandemic led to widespread disruption and cessation of traditional CR programs.
  • This cessation poses significant public health risks due to the well-documented benefits of CR.

Purpose of the Study:

  • To highlight the urgent need for developing remote, home-based CR programs.
  • To advocate for the integration of telemedicine into routine CR care and clinical research.
  • To leverage the current health emergency as an opportunity to advance CR accessibility.

Main Methods:

  • Review of existing literature on remote home-based CR programs.
  • Discussion of the feasibility and benefits of telemedicine in CR delivery.
  • Analysis of the impact of the COVID-19 pandemic on CR service availability.

Main Results:

  • While remote CR literature has grown, implementation has been limited to research settings.
  • The COVID-19 crisis has amplified the relevance and potential of remote CR solutions.
  • Widespread smartphone and internet access facilitate the adoption of home-based CR.

Conclusions:

  • Remote, home-based CR programs are essential to ensure continuity of care during health crises.
  • Telemedicine offers a scalable solution to expand CR access to a larger patient population.
  • Integrating remote CR into clinical practice and research is imperative for future cardiac patient management.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
204
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
3.7K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
252
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
212
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
167
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
162